Abstract
Maternal immune activation (MIA) has emerged as an important environmental risk factor for Autism Spectrum Disorder (ASD). Animal models of MIA have suggested that after an infection and immune activation during pregnancy, maternal proinflammatory cytokines can cross the placenta and impact fetal brain development. Among them, interleukin 17a (IL-17a) has been shown to play an etiological…